These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16895062)

  • 1. [Infliximab in the treatment of Wegener's granulomatosis: case report].
    Svozílková P; Ríhová E; Brichová M; Diblík P; Kuthan P; Poch T
    Cesk Slov Oftalmol; 2006 Jul; 62(4):280-6. PubMed ID: 16895062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients].
    Lamprecht P; Arbach O; Voswinkel J; Lilienthal T; Nölle B; Heller M; Gause A; Gross WL
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1876-80. PubMed ID: 12235553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
    Mukhtyar C; Luqmani R
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wegener's granulomatosis: ocular manifestations, diagnosis and therapy].
    Duncker G; Beigel A; Lehmann H
    Klin Monbl Augenheilkd; 1982 Sep; 181(3):184-7. PubMed ID: 7144012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment.
    Kontkanen M; Paimela L; Kaarniranta K
    Acta Ophthalmol; 2010 May; 88(3):e96-7. PubMed ID: 19758399
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular manifestations of Wegener's granulomatosis in north India.
    Bambery P; Gupta A; Sakhuja V; Kaur U; Gangwar DN; Jain IS; Deodhar SD
    Sarcoidosis; 1988 Sep; 5(2):132-5. PubMed ID: 3227186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin.
    Hagen EC; de Keizer RJ; Andrassy K; van Boven WP; Bruijn JA; van Es LA; van der Woude FJ
    Clin Nephrol; 1995 Jun; 43(6):351-9. PubMed ID: 7554518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for refractory Wegener's granulomatosis: a role for rituximab?
    Antoniu SA
    Curr Opin Investig Drugs; 2007 Nov; 8(11):927-32. PubMed ID: 17979026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab efficiency in refractory Wegener's granulomatosis.
    Rozin A
    Rheumatology (Oxford); 2003 Sep; 42(9):1124-5; author reply 1125-6. PubMed ID: 12923277
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up.
    Odorcic S; Keystone EC; Ma JJ
    Cornea; 2009 Jan; 28(1):89-92. PubMed ID: 19092414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
    Seo P; Specks U; Keogh KA
    J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
    Kleinert J; Lorenz M; Köstler W; Hörl W; Sunder-Plassmann G; Soleiman A
    Wien Klin Wochenschr; 2004 May; 116(9-10):334-8. PubMed ID: 15237661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab in the treatment of refractory posterior uveitis.
    Joseph A; Raj D; Dua HS; Powell PT; Lanyon PC; Powell RJ
    Ophthalmology; 2003 Jul; 110(7):1449-53. PubMed ID: 12867408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis.
    Onal S; Kazokoglu H; Koc A; Yavuz S
    Ocul Immunol Inflamm; 2008; 16(5):230-2. PubMed ID: 19065418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infectious aspects of Wegener's granulomatosis].
    Rusterholz D; Schlegel C
    Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab as rescue therapy in three cases of paediatric Wegener's granulomatosis.
    Wilkinson NM; Erendzhinova E; Zeft A; Cabral DA
    Rheumatology (Oxford); 2006 Aug; 45(8):1047-8. PubMed ID: 16735453
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
    Benitez-del-Castillo JM; Martinez-de-la-Casa JM; Pato-Cour E; Méndez-Fernández R; López-Abad C; Matilla M; Garcia-Sanchez J
    Eye (Lond); 2005 Aug; 19(8):841-5. PubMed ID: 15389273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.